Insider Trading disclosures for Adial Pharmaceuticals Inc

The latest disclosure was made by Claiborne J Cary in Adial Pharmaceuticals Inc where a trade of 350,000 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 5, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Claiborne J Cary	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2024	350,000	350,000	-		-	Stock Option (Right to Buy)
Vinay Shah	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Nov 2024	40,000	40,000	-		-	Stock Option
Cary J Claiborne	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	60,000	60,000	-		-	Stock Option (Right to Buy)
Joseph Truluck	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	25,000	25,000	-		-	Stock Option (Right to Buy)
J. Kermit Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	12,000	12,000	-		-	Stock Option (Right to Buy)
Robertson H. Gilliland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	12,000	12,000	-		-	Stock Option (Right to Buy)
Tony Goodman	Director, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	42,000	42,000	-		-	Stock Option (Right to Buy)
James W. Newman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	12,000	12,000	-		-	Stock Option (Right to Buy)
Kevin Schuyler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	12,000	12,000	-		-	Stock Option (Right to Buy)
Cary J Claiborne	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	420,000	1,520,000 (14%)	4%		0	Common Stock
Cary J Claiborne	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	300,000	300,000	-		-	Stock Option (Right to Buy)
William B. Stilley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	240,800	1,261,779 (12%)	2%		0	Common Stock
William B. Stilley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
Joseph Truluck	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	157,500	265,139 (2%)	1%		0	Common Stock
Joseph Truluck	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	125,000	125,000	-		-	Stock Option (Right to Buy)
J. Kermit Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
Robertson H. Gilliland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
Tony Goodman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
Bankole A. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	40,000	40,000	-		-	Stock Option
James W. Newman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
Kevin Schuyler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	50,000	50,000	-		-	Stock Option (Right to Buy)
William B. Stilley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	30 Dec 2022	166,667	1,020,979 (9%)	1%		0	Common Stock
Cary J Claiborne	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.43 per share.	19 Sep 2022	25,000	1,025,000 (9%)	0%	0.4	10,735	Common Stock
Cary J Claiborne	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.42 per share.	19 Sep 2022	75,000	1,100,000 (10%)	0%	0.4	31,515	Common Stock
William B. Stilley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Aug 2022	100,000	100,000	-		-	Stock Options
Cary J Claiborne	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Aug 2022	1,000,000	1,000,000 (9%)	9%		0	Common Stock
Tony Goodman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jun 2022	25,000	25,000	-		-	Stock Option
Cary J Claiborne	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	6,667	6,667	-		-	Employee Stock Option
William B. Stilley	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	250,000	1,187,646 (11%)	2%		0	Common Stock
Joseph Truluck	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	100,000	100,000	-		-	Employee Stock Option
J. Kermit Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	40,000	40,000	-		-	Stock Option
Robertson H. Gilliland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	40,000	40,000	-		-	Stock Option
Tony Goodman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	40,000	40,000	-		-	Stock Option
Bankole A. Johnson	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	35,000	35,000	-		-	Employee Stock Option
James W. Newman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	40,000	40,000	-		-	Stock Option
Kevin Schuyler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2022	40,000	40,000	-		-	Stock Option
Kevin Schuyler	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	23 Dec 2021	312,990	0 (0%)	3%		0	Common Stock
Kevin Schuyler	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	23 Dec 2021	90,000	0	-		-	Warrant to purchase common stock
Cary J Claiborne	Director, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Dec 2021	130,000	130,000	-		-	Stock options
William B. Stilley	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 2.59 per share.	29 Nov 2021	10,000	927,046 (8%)	0%	2.6	25,892	Common Stock
William B. Stilley	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 2.75 per share.	29 Nov 2021	10,600	937,646 (9%)	0%	2.8	29,179	Common Stock
James W. Newman	Director	Purchase of securities on an exchange or from another person at price $ 2.85 per share.	26 Nov 2021	10,000	34,475 (0%)	0%	2.9	28,500	Common Stock
Cary J Claiborne	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2021	60,000	60,000	-		-	Stock Option
Bankole A. Johnson	Chief Medical Officer	Other type of transaction at price $ 0.00 per share.	04 Oct 2021	150,000	39,714	-		-	Warrant
Bankole A. Johnson	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	04 Oct 2021	200,000	148,246 (1%)	1%		-	Common Stock
Bankole A. Johnson	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 2.50 per share.	06 Apr 2021	150,000	548,336 (5%)	1%	2.5	375,000	Common Stock
William B. Stilley	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	250,000	250,000	-		-	Employee Stock Option
Joseph Truluck	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	125,000	125,000	-		-	Employee Stock Option
J. Kermit Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	40,000	40,000	-		-	Stock Option
Robertson H. Gilliland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	40,000	40,000	-		-	Stock Option

Showing 1 to 50 of 165 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

77.10% Fall from 52W High

Insider Trading disclosures for Adial Pharmaceuticals Inc

The latest disclosure was made by Claiborne J Cary in Adial Pharmaceuticals Inc where a trade of 350,000 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 5, 2024.

Screeners based on Insider Trading and SAST parameters